1 Department of Virology, Swedish Institute for Infectious Disease Control, 171 82 Solna, Sweden
2 St Petersburg Pasteur Institute, 14 Mira Street, St Petersburg 197101, Russia
Correspondence
Olga Kalinina
olgakalinina{at}hotmail.com
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() |
---|
The GenBank accession numbers for the nucleotide sequences reported in this paper are AY587844 and AY587845.
![]() |
MAIN TEXT |
---|
![]() ![]() ![]() ![]() |
---|
The virus genotype is one factor influencing the outcome of interferon (IFN) therapy (Zein, 2000). Infections with genotype 1 are more resistant to IFN therapy than infections with genotypes 2 and 3 (Taylor et al., 2000
). Two domains, the PePHD (PKR-eIF2
phosphorylation site homology domain) in the E2 protein and the ISDR (IFN-
-sensitivity-determining region) in the NS5A protein, are claimed to mediate IFN resistance through inhibition of the PKR (an IFN-
-induced, double-stranded RNA-activated protein kinase), although the importance of the ISDR is still under debate (Enomoto et al., 1996
; Gerotto et al., 1999
; Taylor, 2001
; Taylor et al., 1999
, 2000
, 2001
). There is evidence that only the E2 protein of genotype 1 can bind and inhibit PKR in vitro because of the high similarity that the PePHD sequence of this genotype has to the PKR sequence (Taylor et al., 1999
; Polyak et al., 2000
). The genetic diversity of HCV is therefore critical in our understanding of therapeutic modules against hepatitis C (Farci & Purcell, 2000
).
We have determined the full-length ORFs of two HCV strains, the recombinant RF1_2k/1b (N687) and the most similar non-recombinant subtype 1b strain N589, previously published in part (Kalinina et al., 2002), and predicted the secondary RNA structures around the crossover point for the parental strains to reconstruct the mechanism of recombination.
RNA extraction, cDNA synthesis, strategy of amplification and sequencing of four overlapping fragments covering the E2NS3, NS3NS5A, NS3NS5B and NS5B regions, at positions 25005157, 40366815, 50028638 and 81689396, respectively, were performed mainly as described previously (Kalinina et al., 2002). Overlapping PCR products were sequenced in both directions with internal primers and the primers used in the PCR (Kalinina et al., 2002
). PePHD and ISDR domains for strains N687 and N589 were compared with six strains from GenBank, k1-s2 (subtype 1b; intermediate type), HC-J4 (subtype 1b; wild-type), VAT96 (subtype 2k), HC-J6 (subtype 2a), CB (subtype 3a) and NZL1 (subtype 3a). Similarity and bootscanning analyses were performed with the SIMPLOT program, version 1.2.2 for Windows 95/NT, available from the author S. C. Ray (http://sray.med.som.jhmi.edu/RaySoft/SimPlot/; Lole et al., 1999
) and according to Salminen & Cobb (1998)
.
The deduced polyprotein of the recombinant strain, N687, consisted of 3014 aa with protein sizes according to the parental subtypes (C, 191 aa; E1, 192 aa; E2-HVR, 367 aa; p7, 63 aa; NS2, 217 aa; NS3, 631 aa; NS4A, 54 aa; NS4B, 261 aa; NS5A, 447 aa; and NS5B, 591 aa) without any deletion or insertion related to the recombination site. As previously reported, the recombination point mapped within the NS2 region, most likely at positions 31753176 (Kalinina et al., 2002). This was the only recombination point found in the full-length ORF.
The genetic organization of N589 was similar to that of other HCV subtype 1b strains. As for HC-J4, its putative polyprotein consisted of 3010 aa (C, 191 aa; E1, 192 aa; E2-HVR, 363 aa; p7, 63 aa; NS2, 217 aa; NS3, 631 aa; NS4A, 54 aa; NS4B, 261 aa; NS5A, 447 aa; and NS5B, 591 aa).
PePHD sequences of the recombinant, N687, and 1b strain, N589, were similar to those of genotype 2 and subtype 1b strains, respectively (Fig. 1). Thus, the E2 protein of the recombinant strain should not be able to bind PKR and confer IFN resistance. The ISDR sequence of the recombinant was identical to that of the wild-type subtype 1b associated with IFN resistance (Enomoto et al., 1996
). The 1b strain, N589, had an ISDR sequence corresponding to the intermediate type of Enomoto et al. (1996)
. So far, patients infected with the recombinant have not been subject to IFN therapy, which would contribute to the understanding of the relative importance of the PePHD and the ISDR regions for the outcome of such therapy.
|
A stable hairpin structure, HS1, upstream of the crossover point was predicted for three subtype 1b strains and one 1a strain but not for the recombinant or for other subtypes (Fig. 2a). This structure involves 58 to 88 nt depending on the strain. Two substitutions, G3110A and T3149C, present in the N589 strain compared with k1-s2 abolished two internal loops, whereby a longer stem was formed with a low p-num value (Fig. 2a
). Another hairpin structure, HS2, was predicted downstream of the crossover point, formed by 32 or 60 nt for the subtype 2a and 2k strains, respectively (Fig. 2b
). Five substitutions, G3218, C3224, T3239, A3245 and T3251, in the sequence of subtype 2k strain, VAT96, were critical for the formation of a longer stable hairpin structure of 60 nt with a low p-num value (Fig. 2b
). The hairpin structure of 60 bases contained two bulges (I and II) and one asymmetrical interior loop or U-bulge (III) with a C opposite four U residues (Fig. 2b
). No hairpin structures similar to HS1 and HS2 were predicted close to the crossover junction for the minus-strand sequences of strains N687, N589 or VAT96.
|
In this study, HS1 and HS2 were predicted around the crossover junction for both parental strains but not for the recombinant. Thus, transcriptional pausing of RdRp might be caused by the secondary structure of either parental template. To achieve template switching, the RdRp should be able to bind to the acceptor RNA template. In the TCV system, an efficient 3'-terminal extension on the acceptor RNA was found to depend on several factors. (i) A hairpin structure (designated the motif1 hairpin) on the acceptor genome; (ii) a short base-paired region formed between the acceptor genome and the nascent RNA designated the priming stem; (iii) a spacer region and a U-rich sequence located 5' of the motif1 hairpin that increases the efficacy of 3'-terminal extensions; and (iv) the inability of the RdRp to re-initiate synthesis within the double-stranded region (White & Morris, 1995; Nagy & Simon, 1998a
, b
; Nagy et al., 1998
). The motif1 hairpin binds to the RdRp and may act as an enhancer to recruit the RdRp to the acceptor genome (Nagy & Simon, 1998a
, b
; Nagy et al., 1998
). The possible role of the priming stem is to keep the 3' terminus near the RdRp bound to the hairpin structure and to facilitate 3'-terminal extension. However, in the absence of the motif1 hairpin, the recognition of the priming stem by TCV RdRp is inefficient (Nagy et al., 1998
). HS2 predicted herein for subtype 2k matches the motif1 hairpin predicted for TCV (Fig. 2B
). Similar to HS2, the motif1 hairpin has a tetra-loop cap and a U-bulge, which may play a role in recombination (Nagy & Simon, 1998a
). Deletion of three U residues was found to reduce 3'-terminal extension activity and eliminate in vivo recombination, although it was also shown that the TCV RdRp is likely to recognize the secondary structure of the motif1 hairpin, where individual nucleotides play a minor role (Nagy & Simon, 1998a
; Nagy et al., 1998
). Recently, it was revealed that the RdRps of HCV, bovine viral diarrhoea virus and GB virus-B and the replicase complexes of plant-infecting RNA viruses, such as TCV or brome mosaic bromovirus, may initiate RNA synthesis by a common de novo mechanism, although with distinct preferences for template and substrate initiation nucleotides (Ranjith-Kumar et al., 2002
). This suggests that HS2 has an equal role in HCV recombination as the motif1 hairpin and is involved in the recruitment of the RdRp as an enhancer. The sequence between HS1 and HS2 (nucleotide positions 31753202) did not form a double-stranded stem in any of the templates. This fragment has a short stretch (nucleotide positions 31773188) that is conserved for all genotypes and might serve as a primer during re-initiation of RNA synthesis on the acceptor RNA. HCV RdRp is shown to be capable of non-sequence-specific primer extension independent of the presence of promoter sequences (Behrens et al., 1996
). In addition, there was a poly(A) stretch (nucleotide positions 32703275) in the subtype 2k strain sequence that could play a role as a promoter. Fig. 3
shows the proposed mechanism for formation of the recombinant, RF1_2k/1b.
|
![]() |
ACKNOWLEDGEMENTS |
---|
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() |
---|
De Francesco, R. (1999). Molecular virology of the hepatitis C virus. J Hepatol 31, S47S53.[CrossRef]
Enomoto, N., Sakuma, I., Asahina, Y. & 7 other authors (1996). Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 334, 7781.
Farci, P. & Purcell, R. H. (2000). Clinical significance of hepatitis C virus genotypes and quasispecies. Semin Liver Dis 20, 103126.[Medline]
Figlerowicz, M., Nagy, P. D. & Bujarski, J. J. (1997). A mutation in the putative RNA polymerase gene inhibits nonhomologous, but not homologous, genetic recombination in an RNA virus. Proc Natl Acad Sci U S A 94, 20732078.
Gastaldi, M., Massacrier, A., Planells, R. & 7 other authors (1995). Detection by in situ hybridization of hepatitis C virus positive and negative RNA strands using digoxigenin-labeled cRNA probes in human liver cells. J Hepatol 23, 509518.[CrossRef][Medline]
Gerotto, M., Dal Pero, F., Sullivan, D. G., Chemello, L., Cavalletto, L., Polyak, S. J., Pontisso, P., Gretch, D. R. & Alberti, A. (1999). Evidence for sequence selection within the non-structural 5A gene of hepatitis C virus type 1b during unsuccessful treatment with interferon-. J Viral Hepat 6, 367372.[CrossRef][Medline]
Guillot, S., Caro, V., Cuervo, N., Korotkova, E., Combiescu, M., Persu, A., Aubert-Combiescu, A., Delpeyroux, F. & Crainic, R. (2000). Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol 74, 84348443.
Kalinina, O., Norder, H., Mukomolov, S. & Magnius, L. O. (2002). A natural intergenotypic recombinant of hepatitis C virus identified in St Petersburg. J Virol 76, 40344043.
Lai, M. M. (1992). RNA recombination in animal and plant viruses. Microbiol Rev 56, 6179.[Medline]
Lole, K. S., Bollinger, R. C., Paranjape, R. S., Gadkari, D., Kulkarni, S. S., Novak, N. G., Ingersoll, R., Sheppard, H. W. & Ray, S. C. (1999). Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73, 152160.
Mathews, D. H., Sabina, J., Zuker, M. & Turner, D. H. (1999). Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol 288, 911940.[CrossRef][Medline]
Nagy, P. D. & Simon, A. E. (1998a). In vitro characterization of late steps of RNA recombination in turnip crinkle virus: role of the motif1-hairpin structure. Virology 249, 379392.[CrossRef][Medline]
Nagy, P. D. & Simon, A. E. (1998b). In vitro characterization of late steps of RNA recombination in turnip crinkle virus: the role of the priming stem and flanking sequences. Virology 249, 393405.[CrossRef][Medline]
Nagy, P. D., Zhang, C. & Simon, A. E. (1998). Dissecting RNA recombination in vitro: role of RNA sequences and the viral replicase. EMBO J 17, 23922403.
Nagy, P. D., Pogany, J. & Simon, A. E. (1999). RNA elements required for RNA recombination function as replication enhancers in vitro and in vivo in a plus-strand RNA virus. EMBO J 18, 56535665.
Nouri-Aria, K. T., Sallie, R., Sangar, D., Alexander, G. J., Smith, H., Byrne, J., Portmann, B., Eddleston, A. & Williams, R. (1993). Detection of genomic and intermediate replicative strands of hepatitis C virus in liver tissue by in situ hybridization. J Clin Invest 91, 22262234.[Medline]
Polyak, S. J., Nousbaum, J. B., Larson, A. M., Cotler, S., Carithers, R. L., Jr & Gretch, D. R. (2000). The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferon. J Infect Dis 182, 397404.[CrossRef][Medline]
Ranjith-Kumar, C. T., Gutshall, L., Kim, M. J., Sarisky, R. T. & Kao, C. C. (2002). Requirements for de novo initiation of RNA synthesis by recombinant flaviviral RNA-dependent RNA polymerases. J Virol 76, 1252612536.
Reigadas, S., Ventura, M., Sarih-Cottin, L., Castroviejo, M., Litvak, S. & Astier-Gin, T. (2001). HCV RNA-dependent RNA polymerase replicates in vitro the 3' terminal region of the minus-strand viral RNA more efficiently than the 3' terminal region of the plus RNA. Eur J Biochem 268, 58575867.
Robertson, B., Myers, G., Howard, C. & 14 other authors (1998). Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol 143, 24932503.[CrossRef][Medline]
Salminen, M. O. & Cobb, W. (1998). Bootscanning package for Unix/Linux version 1. National Public Health Institute, Helsinki, Finland. http://www.ktl.fi/hiv
Simmonds, P. (1999). Viral heterogeneity of the hepatitis C virus. J Hepatol 31, S54S60.[CrossRef]
Simmonds, P. (2001). The origin and evolution of hepatitis viruses in humans. J Gen Virol 82, 693712.
Taylor, D. R. (2001). Hepatitis C virus and interferon resistance: it's more than just PKR. Hepatology 33, 15471549.[CrossRef][Medline]
Taylor, D. R., Shi, S. T., Romano, P. R., Barber, G. N. & Lai, M. M. (1999). Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285, 107110.
Taylor, D. R., Shi, S. T. & Lai, M. M. (2000). Hepatitis C virus and interferon resistance. Microbes Infect 2, 17431756.[CrossRef][Medline]
Taylor, D. R., Tian, B., Romano, P. R., Hinnebusch, A. G., Lai, M. M. & Mathews, M. B. (2001). Hepatitis C virus envelope protein E2 does not inhibit PKR by simple competition with autophosphorylation sites in the RNA-binding domain. J Virol 75, 12651273.
Twiddy, S. S. & Holmes, E. C. (2003). The extent of homologous recombination in members of the genus Flavivirus. J Gen Virol 84, 429440.
White, K. A. & Morris, T. J. (1995). RNA determinants of junction site selection in RNA virus recombinants and defective interfering RNAs. RNA 1, 10291040.[Abstract]
Worobey, M., Rambaut, A. & Holmes, E. C. (1999). Widespread intra-serotype recombination in natural populations of dengue virus. Proc Natl Acad Sci U S A 96, 73527351.
Zein, N. N. (2000). Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 13, 223235.
Received 17 January 2004;
accepted 19 April 2004.